← Leaderboards
Georg F Weber
Tufts Medical Center
$921,676
Attributed
$1,021,425
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $479.5K · FY2008–18$500K$375K$250K$125K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$1,021,425 · 3
By mechanism
R15$479,534 · 1
R29$342,392 · 1
R43$199,499 · 1
Top collaborators
- Chitra Edwin1 shared
Others in their field
Top investigators on “Osteopontin”
- Cecilia M. Giachelli · University Of Washington$10,153,679
- Dwight A Towler · Washington University$9,480,817
- Zhigang He · Boston Children'S Hospital$7,210,521
- Jose Luis Millan · Burnham Institute For Medical Research$6,709,916
- Amanda Maria Brown · Johns Hopkins University$6,684,304
- Harvey Cantor · Brigham And Women'S Hospital$6,639,144
Research focus
OsteopontinRna SplicingAntisense Nucleic AcidCell MigrationLaboratory MouseApoptosisTransfectionCd44 MoleculeMetastasisBiological Signal TransductionIntermolecular InteractionGlycosylationAnchorage-Independent GrowthDrug DevelopmentGenesInnovationCellsBiometryAnoikisCessation Of LifeAntibodiesBreast Cancer CellBreastCancer Therapy
Grant awards (5)
Metabolic Mechanisms in Cancer Progression$479,534
R15 · FY2018 · CA · contact PI
THERAPEUTIC ANTI-METASTASIS ANTIBODIES$199,499
R43 · FY2008 · CA
SYNERGISM BETWEEN CD44 AND OSTEOPONTIN IN METASTASIS$117,817
R29 · FY2002 · CA
SYNERGISM BETWEEN CD44 AND OSTEOPONTIN IN METASTASIS$114,090
R29 · FY2001 · CA
SYNERGISM BETWEEN CD44 AND OSTEOPONTIN IN METASTASIS$110,485
R29 · FY2000 · CA